Ensysce Biosciences Inc. (ENSC)
Ensysce Biosciences Statistics
Share Statistics
Ensysce Biosciences has 1.41M shares outstanding. The number of shares has increased by 176.49% in one year.
Shares Outstanding | 1.41M |
Shares Change (YoY) | 176.49% |
Shares Change (QoQ) | 7.68% |
Owned by Institutions (%) | 0% |
Shares Floating | 1.38M |
Failed to Deliver (FTD) Shares | 34 |
FTD / Avg. Volume | 0.09% |
Short Selling Information
The latest short interest is 6.35M, so 486.97% of the outstanding shares have been sold short.
Short Interest | 6.35M |
Short % of Shares Out | 486.97% |
Short % of Float | 494.52% |
Short Ratio (days to cover) | 0.12 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -0.7. Ensysce Biosciences's PEG ratio is 0.
PE Ratio | 0 |
Forward PE | -0.7 |
PS Ratio | 0 |
Forward PS | 0.1 |
PB Ratio | 0 |
P/FCF Ratio | 0 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Ensysce Biosciences.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.42, with a Debt / Equity ratio of 0.08.
Current Ratio | 2.42 |
Quick Ratio | 2.42 |
Debt / Equity | 0.08 |
Debt / EBITDA | -0.04 |
Debt / FCF | -0.04 |
Interest Coverage | 5.22 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-1,141B |
Employee Count | 7 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -78.07% in the last 52 weeks. The beta is 0.65, so Ensysce Biosciences's price volatility has been higher than the market average.
Beta | 0.65 |
52-Week Price Change | -78.07% |
50-Day Moving Average | 5.18 |
200-Day Moving Average | 6.3 |
Relative Strength Index (RSI) | 23.43 |
Average Volume (20 Days) | 36.23K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -6,730.1B |
Net Income | -7,987.2B |
EBITDA | -6,730.1B |
EBIT | -9,277.7B |
Earnings Per Share (EPS) | -4573049.94 |
Balance Sheet
The company has 3.5M in cash and 301.66B in debt, giving a net cash position of -301.66B.
Cash & Cash Equivalents | 3.5M |
Total Debt | 301.66B |
Net Cash | -301.66B |
Retained Earnings | -129,544.3B |
Total Assets | 5.6M |
Working Capital | 3.14M |
Cash Flow
In the last 12 months, operating cash flow was -7,502.7B and capital expenditures 0, giving a free cash flow of -7,502.7B.
Operating Cash Flow | -7,502.7B |
Capital Expenditures | 0 |
Free Cash Flow | -7,502.7B |
FCF Per Share | -4295637.32 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ENSC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ENSC.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Dec 6, 2024. It was a backward split with a ratio of 1:15.
Last Split Date | Dec 6, 2024 |
Split Type | backward |
Split Ratio | 1:15 |
Scores
Altman Z-Score | -34.64 |
Piotroski F-Score | 4 |